Skip to content
Open access

SELENOP-LRP8-mediated macrophage-endothelial cell interaction promotes breast cancer vascular invasion by inducing metabolic reprogramming in endothelial cells

Jul 2026 · Cellular and Molecular Life Sciences · 0 citations

TL;DR

Findings identify a SELENOP + macrophage-endothelial metabolic axis associated with breast cancer VI and support further investigation of combined anti-angiogenic and cholesterol-pathway-directed strategies in preclinical models.

Abstract

Vascular invasion (VI) is an early event in breast cancer dissemination. However, the mechanisms by which macrophages and endothelial cells cooperate to drive this process remain incompletely understood. We aimed to identify macrophage subsets associated with VI and determine how they influence endothelial cell behavior. Single-cell RNA sequencing and spatial transcriptomic profiling and were conducted on breast cancer specimens partitioned by their vascular invasion characteristics. Multiplex immunofluorescence, coculture assays, transcriptomic, proteomic, and metabolomic profiling, molecular docking, and co-immunoprecipitation were used to characterize the SELENOP-LRP8 axis. In vivo validation was conducted using a myeloid-specific Selenop knockout model ( Selenop f/f ; Lyz2 Cre ) bearing E0771 allografts and treated with bevacizumab and/or Ebronucimab. A distinct SELENOP + macrophage subset was enriched in VI-positive breast tumors and exhibited close spatial proximity to endothelial cells. In vitro, macrophage-derived SELENOP enhanced endothelial migration and tube formation. Multi-omics analyses suggested that SELENOP binds endothelial LRP8, leading to cholesterol metabolic rewiring and Hedgehog pathway activation. In the mouse model, Selenop deficiency reduced tumor growth and vascularization, while combination treatment with bevacizumab and Ebronucimab produced the strongest inhibitory effect among the treatment groups. These findings identify a SELENOP + macrophage-endothelial metabolic axis associated with breast cancer VI and support further investigation of combined anti-angiogenic and cholesterol-pathway-directed strategies in preclinical models.

Read PDF

Similar papers

Open access Sep 2026

BET Protein Degrader ZBC260 Induces Tumor Vascular Reprogramming Through Endothelial Cell Remodeling

The transcriptomic and cell–cell communication changes observed are consistent with the establishment of a more immune-permissive tumor microenvironment, supporting the potential of BET degradation as a strategy to complement immunotherapy and improve therapeutic responsiveness in breast cancer.

Deeksha Sharma, Cody G. Hager, Max S. Wicha et al. · 0 citations
Open access Sep 2026

RAMP3 is associated with macrophage-driven immune exclusion and promotes resistance to PD-1 blockade in breast cancer: integrated in vivo and single-cell transcriptomic analyses

The results suggest that RAMP3 contributed to the establishment of an immunosuppressive TME and integration with human clinical datasets supports further investigation of RAMP3 as a potential therapeutic target for overcoming resistance to immune checkpoint therapy in breast cancer.

Yan Zhang, Megumu Tanaka, Takayuki Sakurai et al. · 0 citations
Open access Aug 2026

POSTN⁺ CAF–SPP1⁺ macrophage crosstalk is associated with immune exclusion and poor prognosis in lung adenocarcinoma

A spatially organized POSTN⁺ CAF–SPP1⁺ macrophage niche that may contribute to stromal remodeling, CD8⁺ T-cell exclusion, and potentially reduced immunotherapy benefit in LUAD is defined.

Ankang Zhu, Jian-Yuan Huang, Juan Zhang et al. · 0 citations
Aug 2026

WNK4 restrains endometrial cancer progression by reprogramming macrophage polarization toward an M1-like phenotype

WNK4 acts as an immune-relevant suppressor in endometrial cancer, partly by limiting M2-like polarization and weakening macrophage-driven tumor support, partly by limiting M2-like polarization and weakening macrophage-driven tumor support.

Jia-Rong He, Tian Zhang, Menglan Xiong et al. · 0 citations
Open access Oct 2026

Integrated spatial and single-cell transcriptomics uncover IFI6⁺ regulatory T-cells and SPP1⁺ macrophages immunosuppressive niches in colorectal cancer.

This study uncovered previously unrecognized immunosuppressive cell populations and key immune regulators that advance understanding of CRC immune evasion and highlight potential targets for personalized immunotherapy.

Dominika Miroszewska, Shi-Yang Song, Víctor Urbiola-Salvador et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.